STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Krystal Biotech (NASDAQ: KRYS) will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025 in Miami.

Krish S. Krishnan, Chairman and CEO, will appear in a fireside chat at 10:00 am ET and will host investor meetings throughout the day. A webcast of the presentation will be available beginning at 10:00 am ET on December 3, 2025 and will be posted in the Investors section of the company website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 10:00 am ET on Wednesday, December 3, 2025 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com


FAQ

When will Krystal Biotech (KRYS) present at the Evercore Healthcare Conference?

Krystal Biotech will present on December 3, 2025 at the 8th Annual Evercore Healthcare Conference in Miami.

What time is Krystal Biotech's (KRYS) fireside chat at the Evercore conference?

The fireside chat with Krish S. Krishnan is scheduled for 10:00 am ET on December 3, 2025.

Will Krystal Biotech (KRYS) provide a webcast of its Evercore presentation?

Yes. A webcast will be available beginning at 10:00 am ET on December 3, 2025 and will be posted on the company's Investors website.

Who will represent Krystal Biotech (KRYS) at the Evercore Healthcare Conference?

Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in the fireside chat and meet with investors.

Where can investors watch Krystal Biotech's (KRYS) Evercore presentation replay?

The webcast will be posted in the Investors section of Krystal Biotech's website after the presentation on December 3, 2025.
Krystal Biotech

NASDAQ:KRYS

KRYS Rankings

KRYS Latest News

KRYS Latest SEC Filings

KRYS Stock Data

6.23B
24.74M
11.86%
100.94%
11.91%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
PITTSBURGH